Xu-Sheng Liu

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 11

Top Topics

Vascular Endothelial Growth Factor

Sentinel Lymph Node

Top Venues

Scientific reports

Journal of cellular and molecular medicine

OncoTargets and therapy

Journal of translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Xu-Sheng Liu, Yu Zhang, Zi-Yue Liu, Yan Gao, Ling-Ling Yuan, Dao-Bing Zeng, Fan Tan, Hua-Bing Wan, Zhi-Jun Pei
METTL3 as a novel diagnosis and treatment biomarker and its association with glycolysis, cuproptosis and ceRNA in oesophageal carcinoma. Journal of cellular and molecular medicine 28 (6) (2024)
Xu-Sheng Liu, Chao Liu, Yi-Jia Chen, Dao-Bing Zeng, Ya-Lan Wang, Zhi-Jun Pei
Uterine Burkitt Lymphoma with Rare Extranodal Deposits in the Bone, Breast, and Sacral Canal: A Case Report. OncoTargets and therapy 17 (2024)
Xu-Sheng Liu, Yu Zhang, Zi-Yue Liu, Yan Gao, Ling-Ling Yuan, Dao-Bing Zeng, Fan Tan, Hua-Bing Wan, Zhi-Jun Pei
METTL3 as a novel diagnosis and treatment biomarker and its association with glycolysis, cuproptosis and ceRNA in oesophageal carcinoma. Journal of cellular and molecular medicine 28 (6) (2024)
Xu-Sheng Liu, Chao Liu, Yi-Jia Chen, Dao-Bing Zeng, Ya-Lan Wang, Zhi-Jun Pei
Uterine Burkitt Lymphoma with Rare Extranodal Deposits in the Bone, Breast, and Sacral Canal: A Case Report. OncoTargets and therapy 17 (2024)
Xu-Sheng Liu, Yu-Xuan Chen, Hua-Bing Wan, Ya-Lan Wang, Yang-Yang Wang, Yan Gao, Li-Bing Wu, Zhi-Jun Pei
TRIP6 a potential diagnostic marker for colorectal cancer with glycolysis and immune infiltration association. Scientific reports 14 (1) (2024)
Xu-Sheng Liu, Yu-Xuan Chen, Hua-Bing Wan, Ya-Lan Wang, Yang-Yang Wang, Yan Gao, Li-Bing Wu, Zhi-Jun Pei
TRIP6 a potential diagnostic marker for colorectal cancer with glycolysis and immune infiltration association. Scientific reports 14 (1) (2024)
Xu-Sheng Liu, Yu Zhang, Zi-Yue Liu, Yan Gao, Ling-Ling Yuan, Dao-Bing Zeng, Fan Tan, Hua-Bing Wan, Zhi-Jun Pei
METTL3 as a novel diagnosis and treatment biomarker and its association with glycolysis, cuproptosis and ceRNA in oesophageal carcinoma. Journal of cellular and molecular medicine 28 (6) (2024)
Xu-Sheng Liu, Yu-Xuan Chen, Hua-Bing Wan, Ya-Lan Wang, Yang-Yang Wang, Yan Gao, Li-Bing Wu, Zhi-Jun Pei
TRIP6 a potential diagnostic marker for colorectal cancer with glycolysis and immune infiltration association. Scientific reports 14 (1) (2024)
Xu-Sheng Liu, Yu-Xuan Chen, Hua-Bing Wan, Ya-Lan Wang, Yang-Yang Wang, Yan Gao, Li-Bing Wu, Zhi-Jun Pei
TRIP6 a potential diagnostic marker for colorectal cancer with glycolysis and immune infiltration association. Scientific reports 14 (1) (2024)
Xu-Sheng Liu, Yu-Xuan Chen, Hua-Bing Wan, Ya-Lan Wang, Yang-Yang Wang, Yan Gao, Li-Bing Wu, Zhi-Jun Pei
TRIP6 a potential diagnostic marker for colorectal cancer with glycolysis and immune infiltration association. Scientific reports 14 (1) (2024)
Xu-Sheng Liu, Ling-Ling Yuan, Yan Gao, Xing Ming, Yao-Hua Zhang, Yu Zhang, Zi-Yue Liu, Yi Yang, Zhi-Jun Pei
DARS2 overexpression is associated with PET/CT metabolic parameters and affects glycolytic activity in lung adenocarcinoma. Journal of translational medicine 21 (1) (2023)